Evidence brief · printable

Chronic Kidney Disease evidence brief

One page, every section sourced. Print it or bring it on your phone.

  1. Research Tracker
  2. Evidence briefs
  3. Chronic Kidney Disease

Print or save as PDF Fits on one A4 or Letter page.

Chronic Kidney Disease: evidence brief

Open Source Medicine Foundation · page built 16 November 2026 · trial data searched 2026-11-16 (capped at 1,000 of 2,122 matching trials) · https://research.opensourcemed.info/briefs/chronic-kidney-disease.html

Research information, not medical advice. Prepared to support a conversation with a clinician, not to choose a treatment.

Live version

Medicines with registered trials

Scale: trials listed for each medicine on the tracker's condition page, a snapshot of ClinicalTrials.gov. A trial means it is being studied, not that it works.

  • Soluble Ferric Pyrophosphate 5 trials
  • Epoetin alfa 2 trials
  • Atorvastatin 1 trial
  • ATSM + Health Coach 1 trial
  • Calcitriol - CKD 1 trial
  • CKD Registry 1 trial

Non-drug approaches tested

Scale: trial status on ClinicalTrials.gov (completed, results posted). Status is not a result.

  • Vitamin D 24 trials · 15 completed · 11 with results
  • Education, coaching and self-management 54 trials · 27 completed · 5 with results
  • Curcumin and other polyphenols 7 trials · 5 completed · 4 with results
  • Psychotherapy, counselling and peer support 15 trials · 9 completed · 3 with results
  • Dietary patterns and specific diets 15 trials · 3 completed · 2 with results
  • B vitamins and folate 3 trials · 1 completed · 2 with results

Natural products (RepurpOS Moderate tier)

Scale: RepurpOS evidence tier, from linked trials and literature. Product quality and dose vary.

  • Vitamin D3
  • Zinc
  • Resveratrol
  • Coenzyme Q10
  • Creatine
  • L-Carnitine

Biomarkers reported

Direction in patients compared with the stated comparison group, as reported in the cited study.

  • Cystatin C higher · Taglieri et al. 2009
  • eGFR lower · Li et al. 2024
  • Parathyroid Hormone higher · Jamal et al. 2013
  • Serum Creatinine higher · Benoit et al. 2020
  • Serum Phosphate higher · Petkovich et al. 2011
  • Urinary Albumin-Creatinine Ratio higher · Ruilope et al. 2023

Trials recruiting

Status as recorded on ClinicalTrials.gov when searched (2026-11-16); check the registry for current status and eligibility.

  • Effect of Low Protein Diet on Top of Dapagliflozin on Chronic Kidney Disease in… NCT06281899
  • Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney… NCT07271186
  • Phase 3 Clinical Trial With Dapagliflozin in Chronic Kidney Disease in Adolescents… NCT05944016
  • RaDIANT Health Systems Intervention NCT07033117
  • Expanding and Promoting Alternative Care and kNowledge in Decision-making Trial NCT06243068
  • Physical Exercise and Biomolecular Analysis to Reduce Uremic Toxins in Chronic… NCT06910475

What we don't know yet

Gaps in registered trials, from the evidence-gap map. A gap is not a recommendation.

  • Exercise and physical activity: quality of life 9 trials, no results posted yet
  • Supplements and nutraceuticals: cognition 9 trials, no results posted yet
Sources: ClinicalTrials.gov (trials, status, posted results); RepurpOS natural-product tiers (registry trials, PubMed, reference databases); OSMF biomarker atlas where available; OSMF non-drug evidence map (386 non-drug trials for this condition). Lists are shortened; the live pages carry every entry with its source: evidence-gap map · RepurpOS · condition page · biomarker atlas. Counts change daily. Nothing here is a recommendation to start, stop or change any treatment.